China Galaxy (06881) released its first quarter results with a net profit attributable to equity holders of approximately 3.32 billion yuan, an increase of 10.09% year-on-year.
China Galaxy (06881) released its first quarter results for 2026, with operating income of approximately 7.355 billion yuan, a year-on-year increase of 15.66%; net profit attributable to shareholders of the listed company was approximately 3.32 billion yuan, a year-on-year increase of 10.09%; basic earnings per share was 0.28 yuan.
China Galaxy (06881) announced its performance for the first quarter of 2026, with operating income of approximately RMB 7.355 billion, a year-on-year increase of 15.66%; net profit attributable to shareholders of the listed company was approximately RMB 3.32 billion, a year-on-year increase of 10.09%; basic earnings per share were RMB 0.28.
Related Articles
The antibody-drug conjugate SYS6051 developed by CSPC PHARMA (01093) has been approved for clinical trials in the United States.
DL HOLDINGS GP (01709) predicts that it will hold approximately 700 to 720 bitcoins obtained through bitcoin mining activities by the end of 2026.
On April 28th, BEKE-W (02423) spent approximately $7 million to repurchase approximately 1.3291 million shares.
The antibody-drug conjugate SYS6051 developed by CSPC PHARMA (01093) has been approved for clinical trials in the United States.
DL HOLDINGS GP (01709) predicts that it will hold approximately 700 to 720 bitcoins obtained through bitcoin mining activities by the end of 2026.
On April 28th, BEKE-W (02423) spent approximately $7 million to repurchase approximately 1.3291 million shares.
RECOMMEND
